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For over 15 years, antisense morpholino oligonucleotides (MOs) have allowed developmental biologists to
make key discoveries regarding developmental mechanisms in numerous model organisms. Recently,
serious concerns have been raised as to the specificity of MO effects, and it has been recommended to dis-
continue their usage, despite the long experience of the scientific community with the MO tool in thousands
of studies. Reviewing the many advantages afforded by MOs, we conclude that adequately controlled MOs
should continue to be accepted as generic loss-of-function approach, as otherwise progress in develop-
mental biology will greatly suffer.Introduction
The introduction of antisensemorpholino oligonucleotides (MOs)
(Heasman et al., 2000) has changed the way developmental
biologists study the mechanics and underlying molecular mech-
anisms of embryonic development. MOs have for the first time
allowed the study of gene function directly in non-genetic model
organisms, in particular in the frog Xenopus but also in chicken,
in sea urchin, and in emerging model organisms such as the sea
anemone Nematostella. MOs bind to and thereby block the
translational start site of mRNA molecules; they can also be de-
signed to interfere with mRNA splicing or to protect mRNAs from
microRNA (miRNA)-mediated turnover. As with all sequence-
based intervention tools, MOs are in principle prone to off-target
effects: any given short nucleotide sequence may occur more
than once, in addition to some tolerance of mismatches between
MO and target site. The scientific community has been aware of
these potential pitfalls, guidelines have been published (Eisen
and Smith, 2008) (Box 1), and journal referees and editors in gen-
eral have made sure that agreed-upon standards were adhered
to. Work in zebrafish, however, has recently raised serious con-
cerns as to the specificity of MO effects. A comparison of mor-
phant and mutant phenotypes reported a lack of concordance
in about 70% of cases. The generally more severe morphant
phenotypes were largely ascribed to off-target effects (Kok
et al., 2015). The authors of an accompanying Forum article in
Developmental Cell concluded—at least for the zebrafish com-
munity—that for the time being, MO-mediated phenotypes
should be verified in genetic null backgrounds or by gene editing
approaches (Stainier et al., 2015). Discussing the same issue,
Stainier and colleagues concluded that the description of a MO
phenotype for the first time without the ability to compare with
a genetic mutant should in the future be viewed very critically.
The issue has now transcended the zebrafish community and
has begun to affect grant approvals and paper reviews in com-
munities studying other developmental model organisms, where
genetics is less readily available or undeveloped. These include
cnidarians, molluscs, sea urchins, ascidians, lamprey, amphi-
oxus, and amphibia, where MOs are often the only establishedtargeted loss-of-function approach. In these organisms, as
well as in zebrafish, MOs have allowed enormous progress in
the molecular understanding of developmental mechanisms.
While dominant-negative constructs have been useful, they are
limited to certain protein classes. For these communities, the
sweeping recommendations made based on the Kok et al. paper
are an existential threat.
Here, we argue that Kok et al. should not be taken as an argu-
ment to ban the first-time use of MOs. Instead, adequately
controlled MOs should continue to be accepted as generic
loss-of-function approach in the absence of genetic evidence,
if progress in developmental biology is not to suffer.
Reassessing Kok et al.
Kok et al. (2015) set out to study vascular development and
generated 32 mutant lines in 24 genes, using ZFN, TALEN,
and, in one case, CRISPR/Cas9. With one exception, small dele-
tions and insertions of 2–77 nucleotides were induced near the N
terminus of the encoded proteins, aiming at non-functional trun-
cated proteins and nonsense-mediated decay of mRNA. Spe-
cific abnormalities were recorded in only three mutant lines, in
contrast to corresponding morphants in which abnormalities
were analyzed and reported for 14 of the 24 genes. The authors
extended their analysis to an additional 24 genes, selected from
the 98 ZMP (zebrafish mutation project) mutants for which mor-
phant phenotypes have been published. They found matching
phenotypes in only five cases to conclude, based on both data-
sets, that morphants phenocopy mutants in less than 30% of
cases. Kok et al. (2015) argue that the reasons for these discrep-
ancies were likely MO off-target effects. There is but one
example (megamindum209) where MO injection gives a pheno-
type even in fish in which the MO-targeted part of the gene has
been genome edited to prevent MO binding. The general inter-
pretation, however, seems problematic for a number of reasons.
Close scrutiny reveals that in only a minority of cases (4 out of
48), it has been rigorously demonstrated that the mutant is a null,
with reduced RNA levels recorded for an additional four lines
(Table S1). Thus, the stronger phenotype in morphants mayDevelopmental Cell 35, October 26, 2015 ª2015 Elsevier Inc. 145
Box 1. Currently Used MO Controls, Advantages, and Limitations
In 2008, Eisen and Smith published themost comprehensive guidelines on the use ofMOs for gene knockdown experiments (Eisen
and Smith, 2008). Some journals also provide recommendations concerning MO use in their guidelines for authors (http://www.
elsevier.com/journals/developmental-biology/0012-1606/guide-for-authors). Ideally, absence of protein in the targeted tissues
should be demonstrated by antibody staining or other assays. Antibodies, which work on whole embryos or tissue sections, how-
ever, are not always available, and sufficient amounts to detect proteins on western blots can often not be prepared from embry-
onic samples. Rescue of phenotypes by co-injection of mRNAs not targeted by the MO should be a standard for MO studies, pro-
vided that themRNA injection alone does not produce a phenotype by itself. More than oneMO should be used, including ideally a
splice-inhibiting MO, the effect of which is to be demonstrated by RT-PCR. Simultaneous application of two non-overlapping MOs
at doses below threshold can further be used to prove MO specificity. Experiments should always include the use of control MOs,
for example mismatchMOs which differ in five positions. Control MOs should not affect development when used at the same dose
as the specific MO under investigation. Knockdown experiments should be performed in at least three, ideally five, independent
experiments, and variation of efficacy within and between experiments should be reported, along with statistical evaluation of re-
sults. Of course, comparison with existing mutants may provide a validation of the observed phenotype, even across species in
case of non-genetic model organisms such as Xenopus (cf. Table S2). Limitations include cases of genetic compensation and pro-
cesses, which differ between the vertebrates, such as, for example, neural crest development (Barriga et al., 2015).
In zebrafish, it has been reported that MOs non-specifically induce p53 expression even if the target gene is not involved in cell
survival (Robu et al., 2007). Knockdown of p53 is sometimes used to minimize non-specific effects of MOs in zebrafish (Kok
et al., 2015). The before-mentioned Forum article inDevelopmental Cell proposed to provide dose-response curves for p53 induc-
tion to determine tolerable MO doses (Stainier et al., 2015). In the frog Xenopus, however, p53 knockdown was never used to
prevent unspecific MO effects, indicating a better tolerance. Induction of apoptosis, however, was occasionally investigated,
particularly when studying pathways in which a role of apoptosis had been suggested, such as in neural crest cell specification.
We are not aware of any case of unspecific MO-induced apoptosis. On the contrary, a MO to the actin-binding protein Calponin-2,
which affected directed neural crest cell migration, did not affect apoptosis (Ulmer et al., 2013), nor did control MOs analyzed in
that context (Bonano et al., 2008; Honore´ et al., 2003). However, species differences might exist, as knockdown agents have been
shown to activate p53 in mammalian cells as well, justifying perhaps a necessity for differing standards in differing species.
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morphs, as acknowledged by Kok et al. (2015) for one of their
lines. In addition, rigorous proof of the specificity of morphant
phenotypes was only provided in about half the cases (Table
S1), questioning the significance of the statement that pheno-
types match in less than 30% of cases. An additional general
complication for the comparison of mutant and morphant phe-
notypes in zebrafish arises from extensive genetic diversity
among strains. The authors of a study that analyzed copy num-
ber variants in three commonly used laboratory zebrafish strains
and one native population recommend considering all forms of
genetic variation in biological and medical research using zebra-
fish, as phenotypesmight differ greatly between commonly used
laboratory strains (Brown et al., 2012). While the relevant infor-
mation could not be retrieved in themajority cases, backgrounds
matched in three and differed in five examples (Table S1).
Importantly, as the authors acknowledge, the discrepancies
between morphants and mutants may also be caused by the
fact that mutant embryos from heterozygote crossings lack
only zygotic gene function, while MO targeting additionally in-
hibits maternal mRNA translation. Kok et al. claimed to have
excluded in their analyses cases where genes have maternal
expression. However, scrutiny of e.g., angiomotin (amot) from
their analysis reveals that there is substantial amot expression
at two-cell stage (Harvey et al., 2013; Table S2). In fact, Harvey
et al. report that 61% of zebrafish genes show maternal and zy-
gotic expression, whichmay pose a challenge for mutant studies
in general. Moreover, the authors reporting the amot morphant
(Aase et al., 2007) not only demonstrated the same angiogenesis
phenotype with two independent MOs but also fully rescued the146 Developmental Cell 35, October 26, 2015 ª2015 Elsevier Inc.morphant with mRNA injection. Strikingly, they showed that
amot mutant mice also display a corresponding angiogenesis
defect to the fish morphants. This suggests very strongly that
the failure of Kok et al. to detect vascular defects in their amot
fish mutants is due to incomplete reduction of Amot protein
activity.
In this context it is also interesting and highly relevant that the
group of Didier Stainier recently published a carefully controlled
comparative study where he analyzed the genes EGF-like
domain, multiple 7 (egfl7) and vascular endothelial growth factor
Aa (vegfaa). Again, the mutants revealed milder phenotype while
morphants were severely affected. To investigate possible off-
target effects, MOs were injected into the egfl7 mutant, which
was much less sensitive than wild-type embryos, suggesting
compensatory mechanisms that were activated in the mutant.
emilin3a, an extracellular matrix gene like egfl7, was identified
as a compensating gene, which remarkably was upregulated in
the mutant, but not in morphants or in specimens, in which
egfl7 transcript elongation was inhibited by CRISPR interfer-
ence. In vegfaa mutants, the paralogous gene vegfab was upre-
gulated, which was again not observed in morphants or upon
applying a dominant-negative approach to impair vegfaa func-
tion (Rossi et al., 2015). The lack of the anticipated mutant
phenotypes, which Kok et al. (2015) noted for 21 of their 24 vas-
culogenesis genes, appears in a new light should compensation
of gene loss be more widespread. MO approaches, in contrast,
might get to the function of a given gene more directly by avoid-
ing compensatory mechanisms.
Given these limitations in the interpretation of the reported dis-
crepancies, we believe it is unfounded to conclude that MOs are
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available mutant lines in Xenopus, which were generated by
CRISPR/Cas9, further indicate concordance of phenotypes
with MO data in a majority of cases, for example, for five out of
six genes studied by Khokha and colleagues (M. Khokha, per-
sonal communication). In addition, numerous cases have been
documented in which morphant phenotypes in Xenopus match
mouse and/or zebrafish mutants (Table S2).
Unique Applications of MOs
The use of MOs is very helpful in model organisms with poor
experimental genetics. An excellent example of the power of
antisense MOs in the analysis of sea anemone development
has been published recently (Genikhovich et al., 2015). MOs
are also useful in human clinical trials to induce exon skipping
in Duchenne muscular dystrophy (Cirak et al., 2011). In addition,
MOs have a number of advantages, whichmake them invaluable
even in model organisms in which genetics is in principle an
option.
Precise Spatial Targeting
It is frequent that genes are expressed in many tissues during
development, and therefore, it is desirable to perform loss-of-
function experiments of those genes in a tissue-specific manner,
which can in many cases overcome or delay embryonic lethality.
Although this can be accomplished by genetic tools, it is much
easier to achieve by targeted injection or electroporation of
MOs in suitable species (e.g., Xenopus or chicken; Schweickert
et al., 2010; Ulmer et al., 2013; Ohkawara et al., 2011), if carefully
controlled by co-application of lineage tracer and, ideally, the
absence of protein from the targeted tissue (cf. Box 1).
Targeting Multiple Gene Products
One of the greatest advantages of MO use is the ability to
easily target multiple gene products, which is invaluable for
epistatic analysis and to unravel functional gene redundancy;
these are much more difficult to analyze genetically or by gene
editing.
A great advantage is that one can combine several MOs to
simultaneously knock down multiple genes with similar function.
Studying the role of BMP antagonists in Xenopus, Harland and
colleagues used MOs to generate a triple knockdown of follista-
tin, chordin, and noggin (Khokha et al., 2005). These embryos
showed a catastrophic loss of dorsal structures and neural tis-
sue. By contrast, when only one or two of the antagonists were
blocked, no or only mild effects were observed. In an elegant
control experiment, they showed that knockdown of BMP4
rescued the effect of the triple knockdown. These data clearly
indicated a requirement for BMP antagonists in early axis
formation. Similarly, only quadruple knockdown of ADMP and
BMP2/4/7 embryos eliminated organizer self-regulation in Xeno-
pus, causing the induction of neural tissue over the entire ecto-
derm (Reversade and De Robertis, 2005). These insights into
the nature of embryonic induction would have been extremely
difficult if not impossible to carry out using genetic tools.
Multiple knockdowns have also proven crucial to overcome
functional redundancy between duplicated genes, as they occur
in many species. For example, mutation of sonic hedgehog (shh)
in mouse and humans leads to anterior midline signaling defects.
In contrast, zebrafish shhmutants have normal anterior develop-
ment because the gene is functionally redundant with twhh, asrevealed by double MO knockdown of shh and twhh-MO, which
yields a new phenotype, cyclopia (Nasevicius and Ekker, 2000).
Genetic analysis of epistatic interactions is very challenging.
Combinatorial MO injections have proven a powerful tool to
dissect the epistatic relationship of interacting genes and pro-
teins. For example, the basic sensing mechanism of leftward
flow during left-right symmetry breakage was revealed using
double and triple knockdowns in Xenopus. Impairing ciliary
motility through knockdown of the axonemal dynein motor pro-
teinDanh9 prevented induction of the asymmetric gene cascade
in the left lateral plate mesoderm, which was rescued by parallel
injection of a MO targeting the Nodal inhibitor Dand5 at the left-
right organizer. The additional (triple) knockdown of Xnr1 specif-
ically in the flow-sensing cells reversed the rescue, which
demonstrated that (1) Dand5 acted downstream of leftward
flow, and (2) Xnr1 was the target of Dand5 inhibition (Schweickert
et al., 2010). This scenario was later confirmed in the mouse us-
ing a combination of genetic mutants and experimental manipu-
lations of embryos in culture (Nakamura et al., 2012). In addition,
these experiments were performed by sided injections, assign-
ing left-specific functions to Dnah9 and Nodal and a right-spe-
cific one to Dand5, while injections of the very same MOs at
the very same concentrations on the respective contralateral
sides produced no phenotypes whatsoever. Similarly, combina-
torial MO injections helped reveal the functional hierarchy of pro-
teins involved in Bardet-Biedl syndrome (Badano et al., 2006).
Dose-Dependent Effects
The ability to titrate MOs allows graded knockdown of gene
function. Allelic series can be generated in tractable organisms
such as Drosophila, but it is by no means simple to obtain these
collections. Graded phenotypes can reveal subtle or interme-
diary defects, whichmay bemissed in complete loss-of-function
mutants. For example, dose-response studies with different MO
doses against activin B revealed its role as a morphogen (Pie-
penburg et al., 2004). Such tunable gene inactivation is difficult
to achieve genetically.
Spatiotemporal Gene Regulation In Vivo Using
Photoactivatable MOs
Photoactivatable MOs that can be uncaged by light to initiate
gene inhibition are available. This tunable reagent has been
used to analyze the spatiotemporal regulation of ntl in mosaic ze-
brafish embryos (Shestopalov et al., 2007). Early induction
showed the same phenotype as ntl mutants, while later light-
induced activation revealed differential requirement for chorda-
mesoderm and tail development, respectively, highlighting
the power of this timed inactivation approach. The opposite
approach, photo-inducible gene inactivation, is also possible
with photo-cleavable MOs. If injected as double-stranded MOs
as a sense partner blocking an antisense reagent, UV light will
cleave the sense and allow activation of the antisense strand
at any particular stage of development and region of the embryo.
This approach has been used to demonstrate the sufficiency of
ntl at tail bud stage to drive notochord cell fate (Tallafuss et al.,
2012). Photoactivatable MOs can be combined with studying
the effects of miRNAs on target mRNAs in vivo. Designing
MOs complementary to the miRNA binding sites in the 30
untranslated region of target RNAs protects mRNAs from
miRNA inhibition (Choi et al., 2007), and photoactivation and
inhibition could provide formidable ways of controlling thisDevelopmental Cell 35, October 26, 2015 ª2015 Elsevier Inc. 147
Developmental Cell
Perspectivespatiotemporally. To achieve comparable flexibility in spatiotem-
poral control of gene expression by geneticmeanswould be very
challenging.
Analyzing Maternal Gene Products
Most eggs carry stockpiles of maternal mRNAs and proteins,
which can support gene function into early organogenesis.
Zygotic transcription in many species only starts hours after
fertilization, and early cleavage stages are driven by maternal
factors. Not only is it difficult to study maternal gene products
genetically, maternal components provided in the egg can also
mask the requirement of zygotic gene products after the onset
of transcription. MOs target both maternal and zygotic mRNAs
simultaneously, providing an advantageous situation for the
study of early development.
The study of phenotypes associated with defects in the
maternal RNA supplies requires inhibition of gene products as
they are synthesized during oogenesis. Zygotic gene editing of
eggs or early embryos does not interfere with maternal mRNA
(and in the next generation can result in oogenesis defects and
sterility). In Xenopus, it is possible to inhibit maternally stored
mRNAs in oocytes using antisense oligonucleotides. While
MOs will not inhibit already translated maternal protein, maternal
mRNAs and proteins produced during late oogenesis and early
embryogenesis from maternal mRNA stores can be interfered
with. This has permitted a powerful molecular dissection of
maternal Wnt signaling. In this host transfer assay, antisense
MO-injected oocytes are implanted back into the body
cavity of a host female to render them competent for fertilization.
Using this technique, Heasman and colleagues systematically
dissected the role of individual maternal Wnt pathway com-
ponents (Mir and Heasman, 2008). Genetic or gene editing
analysis of Wnt maternal effect mutants would require gene
expression or targeting during oogenesis. This is cost, labor,
and time intensive, and consequently such studies have yet to
be reported.
Target Protector Morpholinos to Study miRNAs
In the analysis of miRNA function, the interpretation of pheno-
types resulting from genetic inactivation of individual miRNAs
can be challenging. This is because many miRNAs are members
of largemiRNA families present in multiple copies in the genome.
Moreover, miRNA deletion typically causes upregulation of all
the transcripts it regulates not just a particular miRNA-mRNA
pair of interest. To overcome these problems, miRNA function
of specific miRNA-mRNA pairs has been studied by using target
protector MOs, which have been developed in zebrafish (cf. Sta-
ton and Giraldez, 2011 and references therein).
Throwing Out the Baby with the BathWater: The Case of
Antisense and Interfering RNAs
Previous experience shows that not using the full armamen-
tarium available to interrogate biological systems due to prevail-
ing fashion can be costly. When in 1985 Herbert Ja¨ckle and
colleagues showed that one could use antisense RNA injection
into Drosophila embryos to identify the Kru¨ppel gene, there
was great excitement in the scientific community (Rosenberg
et al., 1985). Experiments in a range of organisms gavemixed re-
sults, and this method was gradually felt to be unreliable. How-
ever, the late Herbert Steinbeisser found that an antisense
RNA, directed against BMP4, was very effective in Xenopus148 Developmental Cell 35, October 26, 2015 ª2015 Elsevier Inc.(Steinbeisser et al., 1995). This was probably because BMP4 is
required relatively late in development. Although antisense
BMP4 RNAwas used to demonstrate that BMP4 prevented neu-
ral differentiation in Xenopus (Sasai et al., 1995), prevailing
fashion made this useful reagent fall into disuse. When Andy
Fire and Craig Mello discovered that double-stranded RNA inter-
fered with gene expression (Fire et al., 1998), it became evident
that the results described above may have been due to the for-
mation of RNAi in the microinjected embryos. However, shortly
thereafter, a study in zebrafish by Robert Ho came out showing
that microinjection of double-stranded RNA had non-specific
effects in the zebrafish embryo, probably by triggering an anti-
viral reaction when injected in large amounts (Oates et al.,
2000). Unfortunately, the exploration of antisense or RNAi in
Xenopus or zebrafish ceased immediately, as the field adopted
the newly introduced antisense morpholinos (Heasman et al.,
2000). We should avoid the mistakes of the past as new tech-
niques emerge. As the saying goes, make new friends, but
keep the old, one is silver and the other gold.
Conclusions
In summary, 15 years of MO use in a variety of developmental
model organisms have transformed functional developmental
biology for many organisms. Criteria for adequate controls
have been established, which by and large have worked well.
Artifacts and erroneous interpretations have occurred with
MOs (e.g., Ross et al. 2001; Little and Mullins, 2004), as they
have occurred in genetics and will occur with the emerging
genome modification technologies. Gene editing nucleases
promise to revolutionize developmental biology but, at least for
the time being, cannot replace MOs in many applications. An
ideal scenario involves, where possible, the use of MOs in
conjunction with other genetic tools (mutants, CRISPRi, domi-
nant-negative reagents, etc.). Obtaining the same outcome us-
ing two or more different approaches is far better for science
than any one approach, no matter how well conducted. Scrutiny
of the cases in Kok et al. (2015), however, does not support the
conclusion that MOs are an unreliable tool, which should be
abandoned in the absence of genetic data, because of the
incomplete characterization of most mutants cited. MOs have
many unique advantages that should not be given up lightly,
given the wealth of insight, which has been and will be generated
with them. Banning the use of MOs by reviewers and editors
would cause great harm to developmental biology, not least to
the zebrafish research community, where many of the novel
MO techniques were pioneered.
SUPPLEMENTAL INFORMATION
Supplemental Information includes two tables and can be found with this
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